Adaptive Sample Size Calculations in Group Sequential Trials
From MaRDI portal
Publication:4668352
DOI10.1111/j.0006-341X.1999.01286.xzbMath1059.62671OpenAlexW2069607843WikidataQ47213254 ScholiaQ47213254MaRDI QIDQ4668352
Gernot Wassmer, Walter Lehmacher
Publication date: 18 April 2005
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1111/j.0006-341x.1999.01286.x
Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical analysis (62L10)
Related Items
Optimal Conditional Error Functions for the Control of Conditional Power, Unnamed Item, SEAMLESS PHASE II/III CLINICAL TRIALS WITH COVARIATE ADAPTIVE RANDOMIZATION, An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size, A note on the shape of sample size functions of optimal adaptive two-stage designs, Adaptive designs for subpopulation analysis optimizing utility functions, Unnamed Item, Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers, Adaptive enrichment designs with a continuous biomarker, Discussion on “Adaptive enrichment designs with a continuous biomarker” by N. Stallard, Design aspects of COVID‐19 treatment trials: Improving probability and time of favorable events, Optimization of adaptive designs with respect to a performance score, Adaptive designs with arbitrary dependence structure based on Fisher's combination test, Improving adaptive seamless designs through Bayesian optimization, Exact change point detection with improved power in small‐sample binomial sequences, Sample size re-estimation for confirmatory two-stage flexible multi-arm trial with normal outcomes, Generalized Likelihood Ratio Statistics and Uncertainty Adjustments in Efficient Adaptive Design of Clinical Trials, α-Investing: a Procedure for Sequential Control of Expected False Discoveries, Adaptive Design and Estimation in Randomized Clinical Trials with Correlated Observations, Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials, Optimal two-stage group-sequential designs, Interim Design Modifications in Time-to-Event Studies, Development of Adaptive Group Sequential Procedure for Changing Sample Size, Confidence intervals for the selected population in randomized trials that adapt the population enrolled, Partition testing in confirmatory adaptive designs with structured objectives, Interim Analysis and Sample Size Reassessment, Adaptive dose-finding: Proof of concept with type I error control, Internal pilots for observational studies, Adaptive confidence intervals of desired length and power for normal means, Data-Driven Analysis Strategies for Proportion Studies in Adaptive Group Sequential Test Designs, p-Value calculation for multi-stage additive tests, Monitoring Continuous Long-Term Outcomes in Adaptive Designs, Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches, Monitoring Clinical Trials with Multiple Arms, Sequential Tests for Noninferiority and Superiority, Statistical Inference in Adaptive Group Sequential Trials with the Standardized Mean Difference as Effect Size, Sequential monitoring of response-adaptive randomized clinical trials with sample size re-estimation, Adaptive Multivariate Global Testing, Exact Confidence Bounds Following Adaptive Group Sequential Tests, An Approach to the Conditional Error Rate Principle with Nuisance Parameters, Basic concepts of group sequential and adaptive group sequential test procedures, Adaptive Design for Censored Survival Data Adjusting for Covariates, Are Flexible Designs Sound?, Adaptive designs with arbitrary dependence structure, A comparison of methods for constructing confidence intervals after phase II/III clinical trials, Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications
Cites Work
- Unnamed Item
- Discrete Sequential Boundaries for Clinical Trials
- Approximately Optimal One-Parameter Boundaries for Group Sequential Trials
- Group Sequential Monitoring with Arbitrary Inspection Times
- Designed Extension of Studies Based on Conditional Power
- A Comparison of Two Methods for Adaptive Interim Analyses in Clinical Trials
- On the Power of Fisher's Combination Test for Two Stage Sampling in the Presence of Nuisance Parameters
- Evaluation of Experiments with Adaptive Interim Analyses
- A Two-Sample Test for a Linear Hypothesis Whose Power is Independent of the Variance
